Raymond James Financial Inc Shattuck Labs, Inc. Transaction History
Raymond James Financial Inc
- $280 Billion
- Q2 2025
A detailed history of Raymond James Financial Inc transactions in Shattuck Labs, Inc. stock. As of the latest transaction made, Raymond James Financial Inc holds 250 shares of STTK stock, worth $495. This represents 0.0% of its overall portfolio holdings.
Number of Shares
250Holding current value
$495% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STTK
# of Institutions
64Shares Held
30.4MCall Options Held
36KPut Options Held
0-
Prosight Management, LP Dallas, TX6.64MShares$13.1 Million1.42% of portfolio
-
Redmile Group, LLC San Francisco, CA5.54MShares$11 Million0.53% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.68MShares$9.26 Million0.01% of portfolio
-
Black Rock Inc. New York, NY2.47MShares$4.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$4.25 Million0.0% of portfolio
About Shattuck Labs, Inc.
- Ticker STTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,382,000
- Market Cap $83.9M
- Description
- Shattuck Labs, Inc., a clinical-stage biotechnology company, develops therapeutics for the treatment of cancer and autoimmune disease in the United States. The company's lead product candidate is SL-172154, which is in Phase 1 clinical trial for the treatment of ovarian, fallopian tube, and peritoneal cancers. It also develops SL-279252 that is ...